/PRNewswire/ If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this.
ProSight Global, Inc. (NYSE: PROS)
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of
ProSight Global, Inc. (NYSE: PROS) in connection with the proposed acquisition of the Company by TowerBrook Capital Partners L.P. ( TowerBrook ), and Further Global Capital Management ( Further Global ). Under the terms of the merger agreement, affiliates of TowerBrook and Further Global will acquire all outstanding shares of common stock of PROS for $12.85 per share in cash. If you own PROS shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website:
ProSight to Become Private Company After Being Acquired by Investors
International investment management firm TowerBrook Capital Partners and private equity firm Further Global Capital agreed to acquire 100 percent of the common stock shares of specialty insurer ProSight Global for $586 million cash.
The deal, announced last Friday, means the specialty insurer will move forward as a private company. ProSight went public in July 2019.
The acquisition is expected to close in third-quarter 2021, subject to customary closing conditions, including the receipt of required regulatory approvals. Another closing condition is the completion of a reinsurance transaction with Enstar that will serve to reposition ProSight’s capital in support of future growth, a statement from the acquirers said.
15-06-2020
ProSight Global is to be acquired by private equity firms TowerBrook Capital Partners and Further Global Capital Management in an all-cash transaction valued at $586 million. Meanwhile, the US specialty insurer has entered into a reinsurance deal with Bermuda-based Enstar Group.
The rest of this article is locked. Please login to continue reading.
If you don t have a login, you will need to purchase a subscription to gain access to this article, and all the other content. Please use this link and follow the steps.
To take out a free
two week trial, use the same link but select the trial option in the dropdown box.